prof. dr. Liv Veldeman
- ORCID iD
-
0000-0002-0995-2687
Show
Sort by
-
- Journal Article
- A1
- open access
GRACE-trial : a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy : study protocol
-
- Journal Article
- A1
- open access
Tumor-infiltrating lymphocytes and PD-L1 expression in pleomorphic lobular breast carcinoma
-
- Journal Article
- A1
- open access
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
-
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes
-
- Journal Article
- A1
- open access
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
-
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
-
Predicting patient-reported symptom clusters in prostate cancer patients : a machine learning approach
-
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study
-
- Journal Article
- A1
- open access
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
-
- Journal Article
- A1
- open access
Treatment time and circadian genotype interact to influence radiotherapy side-effects : a prospective European validation study using the REQUITE cohort